Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2

Updated and revised versions of COVID-19 vaccines are vital due to genetic variations of the SARS-CoV-2 spike antigen. Furthermore, vaccines that are safe, cost-effective, and logistic-friendly are critically needed for global equity, especially for middle- to low-income countries. Recombinant prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Seephetdee, Chotiwat, Buasri, Nattawut, Bhukhai, Kanit, Srisanga, Kitima, Manopwisedjaroen, Suwimon, Lertjintanakit, Sarat, Phueakphud, Nut, Pakiranay, Chatbenja, Kangwanrangsan, Niwat, Srichatrapimuk, Sirawat, Kirdlarp, Suppachok, Sungkanuparph, Somnuek, Chutipongtanate, Somchai, Thitithanyanont, Arunee, Hongeng, Suradej, Wongtrakoongate, Patompon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151071/
https://www.ncbi.nlm.nih.gov/pubmed/34066016
http://dx.doi.org/10.3390/vaccines9050498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151071/
https://www.ncbi.nlm.nih.gov/pubmed/34066016
http://dx.doi.org/10.3390/vaccines9050498

Ejemplares similares